SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Dynavax DVAX -- Ignore unavailable to you. Want to Upgrade?


To: scaram(o)uche who wrote (124)5/10/2017 10:27:42 AM
From: scaram(o)uche  Read Replies (1) | Respond to of 184
 
AstraZeneca’s PhIII bid on asthma drug tralokinumab flops

endpts.com

AZD1419 loses an in-house competitor.



To: scaram(o)uche who wrote (124)11/14/2017 9:43:23 AM
From: scaram(o)uche  Respond to of 184
 
AZD1419 trial recently updated.......

dynavax.com

And I don't know if anyone has noted this, but a big step in business plan... phase Ib trial for DV281..... clinicaltrials.gov